Literature DB >> 17374962

Symptomatic dry eye treatment with autologous platelet-rich plasma.

Jorge L Alio1, José R Colecha, Silvia Pastor, Alejandra Rodriguez, Alberto Artola.   

Abstract

BACKGROUND: Autologous platelet-rich plasma (PRP) has been proven to be very effective on tissue regeneration and wound healing. Here we investigate the potential use of PRP in the treatment of symptomatic dry eye.
METHODS: Eighteen consecutive patients with symptomatic dry eye were treated with topical PRP and followed up for 1 month. Disappearance of subjective symptoms, increase in best corrected visual acuity, tear meniscus, tear breakup time, decrease in inflammation, fluorescein staining and improvement in impression cytology were measured.
RESULTS: Symptoms improved significantly in 89% of the patients, 28% improved at least 1 line of best corrected visual acuity. A significant improvement on lachrymal meniscus and conjunctival hyperemia and a decrease or disappearance of corneal fluorescein staining were observed. Impression cytology revealed a significant increase in conjunctival goblet cells.
CONCLUSION: Treatment of patients suffering from significant dry eye symptoms with autologous RPR proved to be very effective, improving both patient symptoms and major clinical signs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17374962     DOI: 10.1159/000100933

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  22 in total

1.  Use of autologous plasma rich in growth factors fibrin membrane in the surgical management of ocular surface diseases.

Authors:  Alfonso L Sabater; Hazem M Mousa; Xavier Quinones; Felipe Valenzuela; Ronald Mauricio Sanchez Avila; Gorka Orive; Eduardo Anitua; Jesús Merayo; Victor L Perez
Journal:  Int Ophthalmol       Date:  2021-03-21       Impact factor: 2.031

2.  Autologous Platelet-Rich Plasma Drops for Evaporative Dry Eye Disease from Meibomian Gland Dysfunction: A Pilot Study.

Authors:  Fahmeeda Murtaza; Dana Toameh; Hannah H Chiu; Eric S Tam; Sohel Somani
Journal:  Clin Ophthalmol       Date:  2022-07-06

Review 3.  Corneal nerves in health and disease.

Authors:  Brittany Simmons Shaheen; May Bakir; Sandeep Jain
Journal:  Surv Ophthalmol       Date:  2014-01-23       Impact factor: 6.048

Review 4.  [Autologous serum and alternative blood products for the treatment of ocular surface disorders].

Authors:  G Geerling; J D Unterlauft; K Kasper; S Schrader; A Opitz; D Hartwig
Journal:  Ophthalmologe       Date:  2008-07       Impact factor: 1.059

Review 5.  Solid Platelet Rich Plasma in Corneal Surgery.

Authors:  Francisco Arnalich; Alejandra E Rodriguez; Alvaro Luque-Rio; Jorge L Alio
Journal:  Ophthalmol Ther       Date:  2016-05-14

Review 6.  Multifocal intraocular lenses: Types, outcomes, complications and how to solve them.

Authors:  Liberdade C Salerno; Mauro C Tiveron; Jorge L Alió
Journal:  Taiwan J Ophthalmol       Date:  2017 Oct-Dec

7.  An integral approach to the etiopathogenesis of human neurodegenerative diseases (HNDDs) and cancer. Possible therapeutic consequences within the frame of the trophic factor withdrawal syndrome (TFWS).

Authors:  Salvador Harguindey; Gorka Orive; Ramón Cacabelos; Enrique Meléndez Hevia; Ramón Díaz de Otazu; Jose Luis Arranz; Eduardo Anitua
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

8.  The Effect of Autologous Platelet Lysate Eye Drops: An In Vivo Confocal Microscopy Study.

Authors:  Antonio M Fea; Vittoria Aragno; Valeria Testa; Federica Machetta; Simone Parisi; Sergio D'Antico; Roberta Spinetta; Enrico Fusaro; Federico M Grignolo
Journal:  Biomed Res Int       Date:  2016-04-20       Impact factor: 3.411

9.  Autologous Platelet-Rich Plasma Eye Drops for the Treatment of Post-LASIK Chronic Ocular Surface Syndrome.

Authors:  Jorge L Alio; Alejandra E Rodriguez; Ahmed A Abdelghany; Renan F Oliveira
Journal:  J Ophthalmol       Date:  2017-12-12       Impact factor: 1.909

10.  Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma.

Authors:  Ronald M Sánchez-Avila; Jesus Merayo-Lloves; Maria Laura Fernández; Luis Alberto Rodríguez-Gutiérrez; Pedro Pablo Rodríguez-Calvo; Andres Fernández-Vega Cueto; Francisco Muruzabal; Gorka Orive; Eduardo Anitua
Journal:  Int Med Case Rep J       Date:  2018-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.